Barbara Ann Karmanos Cancer Institute Launches TheraBionic P1 Device to Treat Advanced Liver Cancer
Dec 18, 2024•12 months ago
Product Description
The Karmanos Cancer Institute announces the availability of the TheraBionic P1, an FDA-approved, at-home treatment device for advanced liver cancer, being the first in the world to prescribe it. This innovative handheld device utilizes radiofrequency electromagnetic fields specifically targeting cancerous tumors.
Product Launch Insights
Based on market dataMarket expansion signals
New product launches often coincide with market expansion initiatives